Triangle-based drug safety company appoints Chief Information Officer
October 27, 2007 (PRLEAP.COM) Health News
DURHAM, N.C. (October 27, 2007) – Drug Safety Alliance Inc. (DSA) has appointed Douglas Hill as chief information officer to oversee its information technology systems. Reliable computer systems and data processing management are critical components to DSA’s drug safety compliance and pharmacovigilance services. Hill will be responsible for developing strategic plans to grow and manage DSA’s technology core in order to provide clients with state-of-the-art drug safety evaluation.Hill was previously president and founder of The Hill Consulting Group, Pittsburgh, PA, which provided IT management and consulting services to pharmaceutical and industrial entities. His experience includes more than 20 years in software maintenance and development, data validation and audit preparation. Hill is also experienced in directing pharmaceutical standards of practice (SOP) in order to achieve industry standard 21 CFR Part 11 compliance.
Hill will be located in DSA’s Durham, N.C. headquarters.
About Drug Safety Alliance
Drug Safety Alliance (DSA) Inc. is a privately held, full-service drug safety management organization located in Durham, North Carolina. DSA’s mission is to partner with clients to mitigate their drug safety risks and to maximize product longevity and value. Driven by the highest ethical standards, DSA is uniquely focused to provide high-quality pharmacovigilance programs to large and small pharmaceutical and biotechnology companies. Pre- and post-market drug safety services include domestic and international regulatory compliance, risk management and adverse event data management. The founders of DSA each hold more than 20 years experience in drug safety and pharmacovigilance management. For more information visit www.drugsafetyalliance.com or call (919) 401-8003.
ContactS:
Jeannine Sato
Public Relations
Fivepointspr@gmail.com
919-225-0122
Drug Safety Alliance
Annette Williams
VP of Operations
Businessdevelopment@drugsafetyalliance.com
919-401-8003
###